SecBot SecBot
SECBOTREPLAY Home › Report › ARWR

ARWR · FMR 13G/A: 6.6% stake

ARROWHEAD PHARMACEUTICALS, INC. · SC 13G/A filed Nov 5, 2026 at 13:10 ET

At the news

NEUTRALIMPACT 2/10

SC 13G/A filed Nov 5, 2026 at 13:10 ET

FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 9,307,349 shares of Arrowhead Pharmaceuticals common stock as of September 30, 2026, representing 6.6% of shares outstanding. This is a routine passive stake update with no change in investment intent.

  • FMR LLC reports 9,307,349 shares of ARWR common stock as of September 30, 2026
  • Stake represents 6.6% of shares outstanding
  • Filing is an amendment to Schedule 13G, confirming passive investment intent
  • Filing made under Rule 13d-1(b), indicating ordinary course investment activity

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access